Optimizing Treatment Strategies for Functional Dyspepsia
Study Objective: To assess the efficacy of three regimens of maintenance therapy, using rabeprazole, in patients who have achieved clinical remission of functional dyspepsia (FD).
Materials and Methods: We examined 80 patients with FD who were diagnosed using the Rome III Diagnostic Criteria. At the time of inclusion, all patients had clinical remission and a history of recurrent dyspepsia (more than 3 episodes within the past 6 months).
All patients underwent a standard examination and self-assessed the intensity of their dyspeptic symptoms, using the Likert rating scale. Depending on the treatment method and the regimen used in the study, patients were divided into four equal groups: Group 1 received rabeprazole every day at a dose of 10 mg/day, Group 2 received rabeprazole every day at a dose of 20 mg/day, Group 3 received rabeprazole at a dose of 20 mg/day (on demand), and Group 4 received antacids and prokinetic agents (on demand). The treatment lasted 3 months.
Study Results: The study showed that a 3-month maintenance treatment with rabeprazole significantly reduced the frequency of dyspepsia recurrences and the intensity of dyspeptic symptoms. Rabeprazole 10 mg/day and 20 mg/day helped maintain clinical remission in 70% and 80% of patients with FD, respectively.
Conclusion: In patients with FD, a 3-month course of rabeprazole 10 mg/day or 20 mg/day reduces the frequency of dyspepsia recurrences and the intensity of dyspeptic symptoms more significantly than prokinetic agents and antacids; this difference is statistically significant.
L. I. Butorova — I. M. Sechenov First Moscow State Medical University. E-mail: email@example.com
M. A. Osadchuk — I. M. Sechenov First Moscow State Medical University. E-mail: firstname.lastname@example.org
M. M. Osadchuk — City Outpatient Clinic No. 52, Moscow Department of Healthсare. E-mail: email@example.com
G. M. Tokmulina — I. M. Sechenov First Moscow State Medical University. E-mail: firstname.lastname@example.org
T. E. Plavnik — City Outpatient Clinic No. 195, Moscow Department of Healthсare. E-mail: email@example.com
N. A. Smirnova — City Outpatient Clinic No. 209, Moscow Department of Healthсare. E-mail: firstname.lastname@example.org
- Ивашкин В. Т., Шептулин А. А., Киприанис В. А. Функциональная диспепсия: краткое практическое руководство. М.: МЕДпресс-информ, 2011. 112 с.
- Шептулин А. А., Колмакова О. З. Синдром неязвенной диспепсии // В кн.: Избранные лекции по гастроэнтерологии / Под ред. В. Т. Ивашкина, А. А. Шептулина. М., 2001. С. 33–35.
- Brun R., Kuo B. Functional dyspepsia // Therap. Adv. Gastroenterol. 2010. Vol. 3. N 3. P. 145–164.
- Corsetti M., Caenepeel P., Fischler B., Janssens J. et al. Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functionaldyspepsia // Am. J. Gastroenterol. 2004. Vol. 99. N 6. P. 1152–1159.
- Di Stefano M., Vos R., Vanuytsel T., Janssens J. et al. Prolonged duodenal acid perfusion and dyspeptic symptom occurrence in healthy volunteers // Neurogastroenterol. Motil. 2009. Vol. 21. N 7. P. 712–717.
- El-Omar E., Penman I., Ardill J. E., McColl K. E. A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients // Gut. 1995. Vol. 36. N 4. P. 534–538.
- Fruehauf H., Steingoetter A., Fox M. R., Kwiatek M. A. et al. Characterization of gastric volume responses and liquid emptying in functional dyspepsia and health by MRI orbarostat and simultaneous C-acetate breath test // Neurogastroenterol. Motil. 2009. Vol. 21. N 7. P. 697–705.
- Haag S., Talley N. J., Holtmann G. Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters // Gut. 2004. Vol. 53. N 10. P. 1445–1451.
- Kamiya T., Shikano M., Mizushima T. et al. Comparison of rabeprazole and itopride in treatment of functional dyspepsia sub-analysis: Nagoya multicentre randomized comparative trial. DDW, New Orleans, 2010. Abstr. T1095.
- Koloski N. A., Talley N. J., Boyce P. M. Epidemiology and health care seeking in the functional GI disorders: a population-based study // Am. J. Gastroenterol. 2002. Vol. 97. N 9. P. 2290–2299.
- Mahadeva S., Goh K. L. Epidemiology of functional dyspepsia: a global perspective // World J. Gastroenterol. 2006. Vol. 12. N 17. P. 2661–2666.
- Moayyedi P., Delaney B. C., Vakil N., Forman D. et al. The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis // Gastroenterology. 2004. Vol. 127. N 5. P. 1329–1337.
- Muller-Lissner S., Koelz H. R. Dyspepsienfibel. Berlin-Heiderlberg-NY, 1991. 67 p.
- Tack J., Talley N. J., Camilleri M., Holtmann G. et al. Functional gastroduodenal disorders // Gastroenterology. 2006. Vol. 130. N 5. P. 1466–1479.
- Talley N. Defining FD: from pathophysiology to indentifying treatment targets // Functional dyspepsia: current evidence and cutting edge outcomes. Abstr. book. Montreal, 2005. P. 21–22.
- Veldhuyzen van Zanten S. J., Chiba N., Armstrong D., Barkun A. et al. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative,primary care patients with dyspepsia: the CADET-HN Study // Am. J. Gastroenterol. 2005. Vol. 100. N 7. P. 1477–1488.
- Zala A. V., Walker M. M., Talley N. J. Emerging drugs for functional dyspepsia // Expert Opin. Emerg. Drugs. 2015. N 2. P. 1–13.
Find original articles and reviews covering various aspects of neurology, psychiatry and the interview with Professor Marina Arkadievna Kinkulkina
Find original articles and reviews covering various aspects of cardiology, gastroenterology, internal medicine and the interview with Professor Elena Zelikovna Golukhova
Find original articles and reviews covering various aspects of pediatrics and the interview with Professor Evgeny Grigorievich Furman
Find original articles and reviews covering various aspects of endocrinology and the interview with Professor Valentin Viktorovich Fadeev
Igor Evgenievich Khatkov, Head of A. S. Loginov Moscow Clinical Scientific and Practical Centre, Chief Oncologist in and for Moscow is now an honoured member of the American Surgical Association.